Condition
Persistent Corneal Epithelial Defects
Total Trials
3
Recruiting
0
Active
0
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 80/100
Termination Rate
33.3%
1 terminated out of 3 trials
Success Rate
0.0%
-86.5% vs benchmark
Late-Stage Pipeline
67%
2 trials in Phase 3/4
Results Transparency
0%
1 of 0 completed with results
Key Signals
1 with results0
Data Visualizations
Phase Distribution
3Total
P 2 (1)
P 3 (2)
Trial Status
Unknown2
Terminated1
Clinical Trials (3)
Showing 3 of 3 trials
NCT05320172Phase 3UnknownPrimary
Platelet Rich Plasma in Corneal Surface Diseases
NCT02153515Phase 3Unknown
Treating Dry Eyes and Corneal Ulcers With Fingerprick Autologous Blood
NCT01165450Phase 2TerminatedPrimary
Efficacy and Safety Study of Nexagon for Persistent Corneal Epithelial Defects
Showing all 3 trials